Synapse - Works

Results (116518)

Prevalence of MGUS is high in the iStopMM study but the prevalence of IgA MGUS does not increase with age in the way other immunoglobulin subtypes do

Meeting Abstract

Love, T. J.; Rögnvaldsson, S.; Thorsteinsdottir, S.; Aspelund, T.; Reed, E. R.; Vidarsson, B.; Onundarson, P. T.; Agnarsson, B. A.; Sigurdardottir, M.; Thorsteinsdottir, I.; more...
Blood (2022)

Fulltext@MSK | Save

The high mobility group A1 chromatin regulator drives immune evasion during MPN progression by repressing genes involved in antigen presentation

Meeting Abstract

Kim, J.; Kim, J. H.; Cope, L.; Li, L.; Rampal, R. K.; Koche, R.; Spivak, J. L.; Moliterno, A. R.; Resar, L.
Blood (2022)

Fulltext@MSK | Save

The menin inhibitor SNDX-5613 (revumenib) leads to durable responses in patients (Pts) with KMT2A-rearranged or NPM1 mutant AML: Updated results of a phase (Ph) 1 study

Meeting Abstract

Issa, G. C.; Aldoss, I.; DiPersio, J. F.; Cuglievan, B.; Stone, R. M.; Arellano, M. L.; Thirman, M. J.; Patel, M. R.; Dickens, D.; Shenoy, S.; more...
Blood (2022)

Fulltext@MSK | Save

Pediatric-specific patterns of clonal evolution arising from acquired aplastic anemia

Meeting Abstract

Oved, J. H.; Shah, Y.; Li, Y.; Monos, D. S.; Babushok, D. V.; Luo, M.; Li, M. M.; Olson, T. S.
Blood (2022)

Fulltext@MSK | Save

Molecular features associated with response to combination therapy with enasidenib (ENA) plus azacitidine (AZA) in newly diagnosed IDH2-mutated acute myeloid leukemia (AML)

Meeting Abstract

Risueño, A.; See, W. L.; DiNardo, C. D.; Döhner, H.; Stein, E.; Fathi, A. T.; Vyas, P.; Quek, L.; Prebet, T.; Gandhi, A. K.; more...
Blood (2022)

Fulltext@MSK | Save

Predicting the need for upfront bone marrow sampling in individuals with MGUS: Derivation of a multivariable prediction model using the prospective population-based iStopMM cohort

Meeting Abstract

Eythorsson, E.; Rögnvaldsson, S.; Thorsteinsdóttir, S.; Reed, E. R.; Sigurdardóttir, G. Á.; Vidarsson, B.; Onundarson, P. T.; Agnarsson, B.; Sigurdardóttir, M.; Ólafsson, I.; more...
Blood (2022)

Fulltext@MSK | Save

A novel bi-specific T-cell engager targeting ILT3 is potently effective in multiple myeloma

Meeting Abstract

Di Meo, F.; Iyer, A.; Akama, K.; Yu, C.; Cheng, R.; Cesarano, A.; Marino, S.; Aljoufi, A.; Soni, R.; Roda, J. M.; more...
Blood (2022)

Fulltext@MSK | Save

Teclistamab, a B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM): Correlative analyses from MajesTEC-1

Meeting Abstract

Cortes-Selva, D.; Casneuf, T.; Vishwamitra, D.; Stein, S.; Perova, T.; Skerget, S.; Ramos, E.; van Steenbergen, L.; De Maeyer, D.; Boominathan, R.; more...
Blood (2022)

Fulltext@MSK | Save

Machine learning approaches incorporating high-dimensional longitudinal data improve the prediction of survival after allogeneic hematopoietic cell transplantation

Meeting Abstract

Zhou, Y. W.; Smith, J.; Keerthi, D.; Sarvode, S.; Shyr, D. C.; Spitzer, B.; Chatterjee, A.; Chatterjee, S.; Naik, S.; Tang, L.; more...
Blood (2022)

Fulltext@MSK | Save

Analysis of 372 adult allograft recipients reveals associations between non-European ancestry, low socioeconomic status, and receipt of HLA-disparate grafts

Meeting Abstract

Fingrut, W.; Chinapen, S.; Katrichis, A.; Carino, C.; Davis, E.; Shaffer, B. C.; Cho, C.; Shah, G. L.; Barker, J. N.
Blood (2022)

Fulltext@MSK | Save